NeuroMetrix Receives FDA 510(k) Clearance for Advance
Long beleaguered NeuroMetrix, which has seen its stock price erode as officials investigate the marketing and misuse of its NC-stat […]
Read more »[Video Profile] Interview with Dr. Randal Chase, CEO of ImmunoVaccine Technologies
ImmunoVaccine Technologies (IVT) is a private biotechnology company developing therapeutic cancer and infectious disease vaccines. VacciMax technology is based on […]
Read more »Merit Medical: Shows Resilience in Faltering Economy; Positioned for Continued Growth
The healthcare equipment sector has a history of resilience. The sector remained strong during the economic downturn earlier this decade […]
Read more »Yulex Receives FDA 510(k) Clearence for Novel Rubber Glove
Latex glove use increased dramatically in the eighties largely as an outgrowth of the AIDS epidemic. Almost unheard of 20 […]
Read more »Biophan Moves Forward with Myotech CSS Development
Pittsford, NY-based Biophan Technologies, will move forward with the next phase of the Myotech Circulatory Support System (CSS) engineering and […]
Read more »OccuLogix Looks to Tears, Hopes to Survive Difficulties
OccuLogix, which traded as high as $1.63 just one year ago, has seen its share price erode as investors lose […]
Read more »Maryland Medicaid Approves ActiPatch Technology for Kidney Compromised Patients
Patients with kidney disease often avoid common pain relievers like aspirin, ibuprofen and naproxen. These medications have the potential to […]
Read more »[Video Profile] Interview with Leah Sparks, VP Business Development of DNA Direct
Medical professional societies have mandated that genetic tests be ordered by a physician and interpreted by a genetic counselor, geneticist, […]
Read more »CryoLife to Distribute Medafor Hemostatic Agent
CryoLife, in a three-year agreement signed last week, will become the exclusive U.S. distributor of Minneapolis, MN-based Medafor’s microporous polysaccharide […]
Read more »Boston Scientific to Acquire CryoCor
Boston Scientific will acquire CryoCor for $17.6 million in cash or $1.35 per share. The buyout comes after a tumultuous […]
Read more »